Crescent Grove Advisors LLC Sells 2,780 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Crescent Grove Advisors LLC reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.3% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 120,761 shares of the exchange traded fund’s stock after selling 2,780 shares during the quarter. SPDR S&P Biotech ETF makes up approximately 1.2% of Crescent Grove Advisors LLC’s holdings, making the stock its 21st biggest holding. Crescent Grove Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $10,783,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC raised its holdings in SPDR S&P Biotech ETF by 26.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 630 shares of the exchange traded fund’s stock worth $52,000 after purchasing an additional 130 shares in the last quarter. James J. Burns & Company LLC grew its position in shares of SPDR S&P Biotech ETF by 5.0% in the 3rd quarter. James J. Burns & Company LLC now owns 3,062 shares of the exchange traded fund’s stock worth $224,000 after buying an additional 146 shares during the period. Integrated Wealth Concepts LLC grew its position in shares of SPDR S&P Biotech ETF by 0.7% in the 2nd quarter. Integrated Wealth Concepts LLC now owns 21,635 shares of the exchange traded fund’s stock worth $1,800,000 after buying an additional 155 shares during the period. Ancora Advisors LLC grew its position in shares of SPDR S&P Biotech ETF by 47.9% in the 1st quarter. Ancora Advisors LLC now owns 491 shares of the exchange traded fund’s stock worth $67,000 after buying an additional 159 shares during the period. Finally, Moser Wealth Advisors LLC grew its position in shares of SPDR S&P Biotech ETF by 10.4% in the 3rd quarter. Moser Wealth Advisors LLC now owns 2,041 shares of the exchange traded fund’s stock worth $149,000 after buying an additional 193 shares during the period.

SPDR S&P Biotech ETF Stock Down 2.1 %

Shares of NYSEARCA:XBI traded down $1.81 during midday trading on Monday, reaching $86.34. The company’s stock had a trading volume of 12,324,179 shares, compared to its average volume of 11,721,593. The firm has a 50 day moving average of $93.99 and a 200-day moving average of $83.95. The firm has a market capitalization of $6.62 billion, a P/E ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a 12-month low of $63.80 and a 12-month high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.